We show that the increase in PGE2 formation in oxaliplatin-resistant colon cancer cells is a result of elevated expression of COX-2 and mPGES-1, with a concomitant decline in the expression of the PGE2 degrading enzyme, 15-PGDH. This evidence concerns the gene HPGD and colonic neoplasm.